{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,4]],"date-time":"2026-10-04T23:33:36Z","timestamp":1791156816499,"version":"4.1.0"},"reference-count":25,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2015,1,20]],"date-time":"2015-01-20T00:00:00Z","timestamp":1421712000000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Breast Cancer"],"published-print":{"date-parts":[[2016,5]]},"DOI":"10.1007\/s12282-015-0583-1","type":"journal-article","created":{"date-parts":[[2015,1,19]],"date-time":"2015-01-19T06:03:28Z","timestamp":1421647408000},"page":"437-444","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":17,"title":["Evaluation of aldehyde dehydrogenase 1 and transcription factors in both primary breast cancer and axillary lymph node metastases as a prognostic factor"],"prefix":"10.1007","volume":"23","author":[{"given":"Maiko","family":"Ito","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tadahiko","family":"Shien","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Masako","family":"Omori","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Taeko","family":"Mizoo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Takayuki","family":"Iwamoto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tomohiro","family":"Nogami","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Takayuki","family":"Motoki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Naruto","family":"Taira","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hiroyoshi","family":"Doihara","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shinichiro","family":"Miyoshi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2015,1,20]]},"reference":[{"key":"583_CR1","doi-asserted-by":"crossref","first-page":"2206","DOI":"10.1093\/annonc\/mdt303","volume":"24","author":"A Goldhirsch","year":"2013","unstructured":"Goldhirsch A, Winer EP, Coates AS, Gelber RD, Piccart-Gebhart M, Thurlimann B, et al. Personalizing the treatment of women with early breast cancer: highlights of the St Gallen international expert consensus on the primary therapy of early breast cancer 2013. Ann Oncol. 2013;24:2206\u201323.","journal-title":"Ann Oncol"},{"key":"583_CR2","doi-asserted-by":"crossref","first-page":"1883","DOI":"10.1158\/0008-5472.CAN-05-3153","volume":"66","author":"MS Wicha","year":"2006","unstructured":"Wicha MS, Liu S, Dontu G. Cancer stem cells: an old idea\u2014a paradigm shift. Cancer Res. 2006;66:1883\u201390 (discussion 1895\u20131896).","journal-title":"Cancer Res"},{"key":"583_CR3","doi-asserted-by":"crossref","first-page":"555","DOI":"10.1016\/j.stem.2007.08.014","volume":"1","author":"C Ginestier","year":"2007","unstructured":"Ginestier C, Hur MH, Charafe-Jauffret E, Monville F, Dutcher J, Brown M, et al. ALDH1 is a marker of normal and malignant human mammary stem cells and a predictor of poor clinical outcome. Cell Stem Cell. 2007;1:555\u201367.","journal-title":"Cell Stem Cell"},{"key":"583_CR4","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1007\/s12282-012-0350-5","volume":"21","author":"T Nogami","year":"2014","unstructured":"Nogami T, Shien T, Tanaka T, Nishiyama K, Mizoo T, Iwamto T, et al. Expression of ALDH1 in axillary lymph node metastases is a prognostic factor of poor clinical outcome in breast cancer patients with 1-3 lymph node metastases. Breast Cancer. 2014;21:58\u201365.","journal-title":"Breast Cancer"},{"key":"583_CR5","doi-asserted-by":"crossref","first-page":"871","DOI":"10.1016\/j.cell.2009.11.007","volume":"139","author":"JP Thiery","year":"2009","unstructured":"Thiery JP, Acloque H, Huang RY, Nieto MA. Epithelial-mesenchymal transitions in development and disease. Cell. 2009;139:871\u201390.","journal-title":"Cell"},{"key":"583_CR6","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1186\/bcr2416","volume":"11","author":"E Tomaskovic-Crook","year":"2009","unstructured":"Tomaskovic-Crook E, Thompson EW, Thiery JP. Epithelial to mesenchymal transition and breast cancer. Breast Cancer Res. 2009;11:213.","journal-title":"Breast Cancer Res"},{"key":"583_CR7","doi-asserted-by":"crossref","first-page":"704","DOI":"10.1016\/j.cell.2008.03.027","volume":"133","author":"SA Mani","year":"2008","unstructured":"Mani SA, Guo W, Liao MJ, Eaton EN, Ayyanan A, Zhou AY, et al. The epithelial-mesenchymal transition generates cells with properties of stem cells. Cell. 2008;133:704\u201315.","journal-title":"Cell"},{"key":"583_CR8","doi-asserted-by":"crossref","first-page":"659","DOI":"10.1016\/j.bbrc.2010.07.138","volume":"399","author":"LE Lindley","year":"2010","unstructured":"Lindley LE, Briegel KJ. Molecular characterization of TGFbeta-induced epithelial-mesenchymal transition in normal finite lifespan human mammary epithelial cells. Biochem Biophys Res Commun. 2010;399:659\u201364.","journal-title":"Biochem Biophys Res Commun"},{"key":"583_CR9","doi-asserted-by":"crossref","first-page":"488","DOI":"10.1245\/ASO.2005.04.010","volume":"12","author":"TA Martin","year":"2005","unstructured":"Martin TA, Goyal A, Watkins G, Jiang WG. Expression of the transcription factors snail, slug, and twist and their clinical significance in human breast cancer. Ann Surg Oncol. 2005;12:488\u201396.","journal-title":"Ann Surg Oncol"},{"key":"583_CR10","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1007\/s10549-011-1684-y","volume":"133","author":"JG Nes van","year":"2012","unstructured":"van Nes JG, de Kruijf EM, Putter H, Faratian D, Munro A, Campbell F, et al. Co-expression of SNAIL and TWIST determines prognosis in estrogen receptor-positive early breast cancer patients. Breast Cancer Res Treat. 2012;133:49\u201359.","journal-title":"Breast Cancer Res Treat"},{"key":"583_CR11","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1186\/1471-2407-11-73","volume":"11","author":"Y Soini","year":"2011","unstructured":"Soini Y, Tuhkanen H, Sironen R, Virtanen I, Kataja V, Auvinen P, et al. Transcription factors zeb1, twist and snai1 in breast carcinoma. BMC Cancer. 2011;11:73.","journal-title":"BMC Cancer"},{"key":"583_CR12","doi-asserted-by":"crossref","first-page":"607","DOI":"10.1590\/S1807-59322011000400014","volume":"66","author":"ST Carvalho","year":"2011","unstructured":"Carvalho ST, Stiepcich MM, Fregnani JH, Nonogaki S, Rocha R, Soares FA. Evaluation of prognostic factors in stage IIA breast tumors and their correlation with mortality risk. Clinics. 2011;66:607\u201312.","journal-title":"Clinics"},{"key":"583_CR13","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1007\/s10549-013-2442-0","volume":"138","author":"P Karihtala","year":"2013","unstructured":"Karihtala P, Auvinen P, Kauppila S, Haapasaari KM, Jukkola-Vuorinen A, Soini Y. Vimentin, zeb1 and Sip1 are up-regulated in triple-negative and basal-like breast cancers: association with an aggressive tumour phenotype. Breast Cancer Res Treat. 2013;138:81\u201390.","journal-title":"Breast Cancer Res Treat"},{"key":"583_CR14","doi-asserted-by":"crossref","first-page":"226","DOI":"10.1186\/1479-5876-10-226","volume":"10","author":"A Markiewicz","year":"2012","unstructured":"Markiewicz A, Ahrends T, Welnicka-Jaskiewicz M, Seroczynska B, Skokowski J, Jaskiewicz J, et al. Expression of epithelial to mesenchymal transition-related markers in lymph node metastases as a surrogate for primary tumor metastatic potential in breast cancer. J Transl Med. 2012;10:226.","journal-title":"J Transl Med"},{"key":"583_CR15","doi-asserted-by":"crossref","first-page":"555","DOI":"10.1016\/j.prp.2013.05.007","volume":"209","author":"Y Dong","year":"2013","unstructured":"Dong Y, Bi LR, Xu N, Yang HM, Zhang HT, Ding Y, et al. The expression of aldehyde dehydrogenase 1 in invasive primary breast tumors and axillary lymph node metastases is associated with poor clinical prognosis. Pathol Res Pract. 2013;209:555\u201361.","journal-title":"Pathol Res Pract"},{"key":"583_CR16","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1186\/1471-2407-12-42","volume":"12","author":"JS Mieog","year":"2012","unstructured":"Mieog JS, de Kruijf EM, Bastiaannet E, Kuppen PJ, Sajet A, de Craen AJ, et al. Age determines the prognostic role of the cancer stem cell marker aldehyde dehydrogenase-1 in breast cancer. BMC Cancer. 2012;12:42.","journal-title":"BMC Cancer"},{"key":"583_CR17","doi-asserted-by":"crossref","first-page":"1062","DOI":"10.1111\/j.1349-7006.2009.01151.x","volume":"100","author":"K Morimoto","year":"2009","unstructured":"Morimoto K, Kim SJ, Tanei T, Shimazu K, Tanji Y, Taguchi T, et al. Stem cell marker aldehyde dehydrogenase 1-positive breast cancers are characterized by negative estrogen receptor, positive human epidermal growth factor receptor type 2, and high Ki67 expression. Cancer Sci. 2009;100:1062\u20138.","journal-title":"Cancer Sci"},{"key":"583_CR18","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1016\/j.yexmp.2012.09.003","volume":"94","author":"I Alkatout","year":"2013","unstructured":"Alkatout I, Wiedermann M, Bauer M, Wenners A, Jonat W, Klapper W. Transcription factors associated with epithelial-mesenchymal transition and cancer stem cells in the tumor centre and margin of invasive breast cancer. Exp Mol Pathol. 2013;94:168\u201373.","journal-title":"Exp Mol Pathol"},{"key":"583_CR19","doi-asserted-by":"crossref","first-page":"294","DOI":"10.1016\/j.semcdb.2008.02.001","volume":"19","author":"B Baum","year":"2008","unstructured":"Baum B, Settleman J, Quinlan MP. Transitions between epithelial and mesenchymal states in development and disease. Semin Cell Dev Biol. 2008;19:294\u2013308.","journal-title":"Semin Cell Dev Biol"},{"key":"583_CR20","doi-asserted-by":"crossref","first-page":"7135","DOI":"10.1158\/0008-5472.CAN-09-1618","volume":"69","author":"T Tsuji","year":"2009","unstructured":"Tsuji T, Ibaragi S, Hu GF. Epithelial-mesenchymal transition and cell cooperativity in metastasis. Cancer Res. 2009;69:7135\u20139.","journal-title":"Cancer Res"},{"key":"583_CR21","doi-asserted-by":"crossref","first-page":"5395","DOI":"10.1158\/1078-0432.CCR-06-0478","volume":"12","author":"C Come","year":"2006","unstructured":"Come C, Magnino F, Bibeau F, De Santa Barbara P, Becker KF, Theillet C, et al. Snail and slug play distinct roles during breast carcinoma progression. Clin Cancer Res. 2006;12:5395\u2013402.","journal-title":"Clin Cancer Res"},{"key":"583_CR22","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1186\/1471-2407-11-49","volume":"11","author":"J Li","year":"2011","unstructured":"Li J, Zhou BP. Activation of beta-catenin and Akt pathways by Twist are critical for the maintenance of EMT associated cancer stem cell-like characters. BMC Cancer. 2011;11:49.","journal-title":"BMC Cancer"},{"key":"583_CR23","doi-asserted-by":"crossref","first-page":"e66558","DOI":"10.1371\/journal.pone.0066558","volume":"8","author":"S Lim","year":"2013","unstructured":"Lim S, Becker A, Zimmer A, Lu J, Buettner R, Kirfel J. SNAI1-mediated epithelial-mesenchymal transition confers chemoresistance and cellular plasticity by regulating genes involved in cell death and stem cell maintenance. PLoS One. 2013;8:e66558. doi: 10.1371\/journal.pone.0066558 .","journal-title":"PLoS One"},{"key":"583_CR24","doi-asserted-by":"crossref","first-page":"R101","DOI":"10.1186\/bcr3042","volume":"13","author":"L Wei","year":"2011","unstructured":"Wei L, Liu TT, Wang HH, Hong HM, Yu AL, Feng HP, et al. Hsp27 participates in the maintenance of breast cancer stem cells through regulation of epithelial\u2013mesenchymal transition and nuclear factor-kappaB. Breast Cancer Res. 2011;13:R101.","journal-title":"Breast Cancer Res"},{"key":"583_CR25","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1016\/j.ctrv.2013.09.008","volume":"40","author":"P Mallini","year":"2014","unstructured":"Mallini P, Lennard T, Kirby J, Meeson A. Epithelial-to-mesenchymal transition: what is the impact on breast cancer stem cells and drug resistance. Cancer Treat Rev. 2014;40:341\u20138.","journal-title":"Cancer Treat Rev"}],"container-title":["Breast Cancer"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s12282-015-0583-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s12282-015-0583-1\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s12282-015-0583-1","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,6,3]],"date-time":"2019-06-03T16:40:57Z","timestamp":1559580057000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s12282-015-0583-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,1,20]]},"references-count":25,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2016,5]]}},"alternative-id":["583"],"URL":"https:\/\/doi.org\/10.1007\/s12282-015-0583-1","relation":{},"ISSN":["1340-6868","1880-4233"],"issn-type":[{"value":"1340-6868","type":"print"},{"value":"1880-4233","type":"electronic"}],"subject":[],"published":{"date-parts":[[2015,1,20]]}}}